Tuesday, February 10, 2026
ADVT 
International

US state's Senate passes bill to allow fireworks during Diwali

Darpan News Desk IANS, 07 Feb, 2023 12:53 PM
  • US state's Senate passes bill to allow fireworks during Diwali

Photo courtesy of IStock. 

New York, Feb 7 (IANS) Lawmakers at the Utah Senate in the US unanimously passed a bill that will make Diwali a state commemorative period, and allow discharge of fireworks during the Indian festival of lights.

Moved by Senator Lincoln Fillmore from South Jordan, the Senate Bill 46 was approved unanimously last week, ABC4 reported.

The bill would designate Diwali as a state commemorative period and will allow the sale and discharge of fireworks during the five days of Diwali, which is usually between late October and early November.

Fillmore said one of his constituents in Herriman reached out to him and gave him the idea for this bill, which needs just one more vote before heading to the House of Representatives.

"I appreciate Utah's Indian community. Their collaborative efforts to organise events to include the neighbouring communities, as well as their efforts to increase education about Hinduism, Jainism and Sikhism, have helped create a better sense of understanding in our state," Senator Fillmore said in a statement.

"This bill recognises others' cultures, contributing to the wonderful tapestry that is Utah."

The bill will be scheduled for a third reading at the Utah Senate in the near future.

Diwali was celebrated in the White House for the first time in 2002, and in 2007, the US government gave official recognition to the festival.

In 2021, the Diwali Day Act was introduced in the US to declare the festival a federal holiday.

This year, Diwali will fall on November 12.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK